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Abstract
In the dorsal striatum, there are two major populations of medium spiny projection neurons. One population is positive for
dynorphin mRNA (DYN+), and these cells project preferentially to the substantia nigra, forming the so-called `direct pathway'. A
second population is positive for enkephalin mRNA (ENK+), and these cells in¯uence the substantia nigra indirectly, via the
globus pallidus and subthalamic nucleus. Psychostimulant drugs, such as amphetamine and cocaine, are reported to induce
immediate early genes (IEGs) in only one subpopulation of dorsal striatal projection neurons, DYN+ cells. However, this apparent
selectivity appears to be a function of environmental context. We found that when given in the animal's home cage, amphetamine
and cocaine increased expression of the IEG, c-fos, almost exclusively in DYN+ cells. However, when given in a novel
environment, amphetamine and cocaine increased c-fos mRNA in both DYN+ and ENK+ cells. Furthermore, amphetamine and
cocaine increased c-fos mRNA expression in the subthalamic nucleus when administered in the novel environment, but not when
given at home. We conclude that the neural circuitry engaged by psychostimulant drugs, and their ability to induce speci®c
patterns of gene expression, are determined by the environmental context in which they are experienced. This may be related to
the ability of environmental novelty to facilitate psychostimulant drug-induced neuroplasticity.
Introduction
Psychostimulant drugs, such as amphetamine and cocaine, induce the
expression of immediate early genes (IEGs) in neurons throughout
the striatal complex (Graybiel et al., 1990; Young et al., 1991; Berke
et al., 1998). This may re¯ect their ability to engage striatal circuitry
(Dragunow & Faull, 1989), and also may be indicative of an initial
step in the development of cellular adaptations underlying drug
experience-dependent plasticity (Morgan & Curran, 1991; Nestler
et al., 1993). There are two neurochemically distinct populations of
medium spiny projection neurons in the striatum (Albin et al., 1989;
Alexander & Crutcher, 1990; Gerfen et al., 1990), and there have
been many studies designed to delineate which population expresses
IEGs following psychostimulant drug administration. There is almost
complete consensus that amphetamine and cocaine induce IEG
expression only in striatal neurons that are positive for prodynorphin
mRNA (dynorphin+, DYN+, or enkephalin-negative, ENK±, neu-
rons). These neurons project preferentially to the substantia nigra,
forming the so-called `direct' pathway. Amphetamine and cocaine
reportedly fail to induce IEGs in striatal neurons that are positive for
proenkephalin mRNA (ENK+ neurons), which project preferentially
to the pallidum and subthalamic nucleus (STN), forming the so-called
`indirect' pathway (Berretta et al., 1992, 1993; Cenci et al., 1992a, b;
Johansson et al., 1994; Ruskin & Marshall, 1994; Kosofsky et al.,
1995; Moratalla et al., 1996; Berke et al., 1998; Harlan & Garcia,
1998).
We have found, however, that the ability of amphetamine to induce
the IEG, c-fos, is modulated powerfully by the environmental context
in which it is experienced. In the striatum, for example, amphetamine
induces much higher levels of c-fos mRNA when it is given in a novel
environment, relative to when it is given in the home cage (Badiani
et al., 1998). Also, consistent with the literature, we found that when
amphetamine was given at home it induced c-fos mRNA expression
in cells positive for dopamine (DA) D1 receptor mRNA (the DYN+
cells), but not in cells positive for DA D2 receptor mRNA (the ENK+
cells). In contrast, when we gave amphetamine in a novel environ-
ment it induced c-fos mRNA expression in both D1 and D2 mRNA+
cells (Badiani et al., 1999). This suggests that the context in which
amphetamine is experienced may not only modulate the magnitude of
IEG expression, but may determine which populations of striatal cells
are engaged.
To further address this issue we have characterized the ability of
amphetamine to induce the IEG, c-fos, in neurochemically distinct
striatal cell populations, as a function of environmental context, but
using probes for either proenkephalin mRNA (to identify the ENK+
cell population) or prodynorphin mRNA (to identify the ENK± cell
population). In addition, in our earlier experiments we quanti®ed c-
fos expression in the intact hemisphere of rats that had a unilateral 6-
hydroxydopamine (6-OHDA) lesion (Badiani et al., 1998, 1999).
This is potentially problematic because a unilateral 6-OHDA lesion
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may alter neurotransmission even in the intact hemisphere (e.g.
Robinson, 1991), and therefore, the present study was conducted
using neurologically intact rats. Also, in our previous experiment we
only studied amphetamine, and in the present experiment we sought
to determine if environmental context has a similar effect on c-fos
expression evoked by cocaine. Finally, to further explore the
involvement of the `indirect' pathway, we also examined c-fos
expression in the STN, one component of this circuit.
Materials and methods
Subjects
Fifty-six male Sprague±Dawley rats (Harlan, Indianapolis, IN, USA)
weighing 200±250 g were housed initially in stainless steel hanging
cages in a temperature- and humidity-controlled colony room. The
rats were kept on a 14 : 10 h light : dark cycle (lights on at 07.00 h)
and were given food and water ad libitum. The animals were kept in
the colony room for 7 days before any experimental manipulation.
The experimental procedures were approved by the University of
Michigan Committee on the Use and Care of Animals.
Testing procedures
Rats were assigned to one of seven groups. Animals in three groups
were housed singly in 40.6 3 25.4 3 20.3 cm high white plastic tubs
with ground corncob bedding on the ¯oor. Animals in three other
groups were housed singly in stainless steel hanging cages. After
10 days of adaptation to these housing conditions, animals in these
six groups received an intraperitoneal (i.p.) injection of saline or drug
in the white plastic tubs. Thus, three groups were administered saline
(home/saline group, n = 5), 1.5 mg/kg of amphetamine (home/
amphetamine group, n = 9) or 15 mg/kg of cocaine (home/cocaine
group, n = 9) in their home cages, whereas animals in the other three
groups were transferred from their home cages to novel test cages
(white plastic tubs), where they immediately received saline (novelty
group, n = 9), 1.5 mg/kg of amphetamine (novel/amphetamine
group, n = 11) or 15 mg/kg of cocaine (novel/cocaine group,
n = 9). Note that all animals received their injections in physically
identical cages, but for some animals this was home and for others it
was a novel environment. In addition, a seventh group was housed in
the white plastic tubs but received no injections (untreated group,
n = 4).
Drugs
D-amphetamine sulphate (1.5 mg/mL) and cocaine HCl (15 mg/mL)
were dissolved in 0.9% saline. All drug weights refer to the weight of
the salts. Drug solutions were administered by i.p. injection (1 mL/
kg) and control treatments consisted of saline.
In situ hybridization methods
Fifty minutes following drug treatments, the rats were decapitated,
their brains were removed and immediately frozen in isopentane (±40
to ±50 °C), and then stored in a ±70 °C freezer. Coronal brain
sections (10 mm) were cut using a cryostat. Brain sections were taken
at the level of the dorsal striatum and the STN (at approximately
0.8 mm posterior and 4 mm posterior to bregma, respectively), thaw-
mounted on slides coated with polylysine and stored at ±70 °C until
processing for in situ hybridization. This level of the dorsal striatum
was chosen because it is where we have previously found the largest
effect of environmental context on amphetamine-induced c-fos
expression (Badiani et al., 1998).
The single in situ hybridization method was adapted from that
described by Cullinan et al. (1995) and the double in situ
hybridization method from that described by Curran & Watson
(1995). Brie¯y, brain sections were ®xed in 4% paraformaldehyde.
Sections containing the STN were processed for single in situ
hybridization using 35S-UTP and CTP-labelled riboprobes comple-
mentary to c-fos (680-mer; courtesy of Dr T. Curran, St Jude
Children's Research Hospital, Memphis, TN, USA). Sections
FIG. 1. The expression of c-fos mRNA in the dorsal striatum of rats given
cocaine or amphetamine at home, or in a novel environment, or given saline
in a novel environment. The illustrations to the right of each panel contain
stippled regions that indicate the area of the dorsal striatum that was
quanti®ed. (A) The mean (6 SEM) number of cells positive for c-fos
mRNA as a function of drug and environment. The mean (6 SEM) for the
control group was 0.222 6 0.15, and this number was subtracted from the
value for each animal in all experimental groups. Thus, the mean of the
control group is represented by a value of zero, and all values greater than
zero indicate signi®cant expression. All groups showed greater expression
than the control group (one-sample t-tests; novel/saline, t = 7.19,
P < 0.0001; home/cocaine, t = 2.79, P < 0.02; novel/cocaine, t = 8.34,
P < 0.0001; home/amphetamine, t = 4.84, P < 0.002; novel/amphetamine,
t = 6.14, P < 0.0003). Animals given cocaine or amphetamine in the novel
environment showed higher levels of expression than animals treated at
home (novel/cocaine vs. home/cocaine, t = 4.86, P < 0.0001; novel/
amphetamine vs. home/amphetamine, t = 2.97, P < 0.009). Both the novel/
cocaine and novel/amphetamine groups differed from the saline group
(t = 2.68±5.52, P < 0.02). (B) The mean (6 SEM) number of cells positive
for c-fos mRNA that were also positive for either dynorphin (DYN) mRNA
or enkephalin (ENK) mRNA, as a function of drug and environment. In the
control group, no ENK+ cells were positive for c-fos mRNA, and only
0.222 6 0.15 DYN+ cells were positive for c-fos mRNA. In all groups,
there was an increase in the number DYN+ cells that expressed c-fos
mRNA, relative to the control group (novel/saline, t = 3.5, P < 0.009;
home/cocaine, t = 3.1, P < 0.02; novel/cocaine, t = 7.95, P < 0.0001; home/
amphetamine, t = 4.25, P < 0.003; novel/amphetamine, t = 7.01,
P < 0.0001). Also, in all groups except the home/amphetamine group, there
was an increase in the number of ENK+ cells that expressed c-fos, relative
to the control group (novel/saline, t = 3.1, P < 0.015; home/cocaine, t = 2.5,
P < 0.038; novel/cocaine, t = 4.05, P < 0.004; home/amphetamine, t = 1.79,
P = 0.11; novel/amphetamine, t = 4.31, P < 0.002). There was no effect of
environment on the number of DYN+ cells that expressed c-fos mRNA
(novel/cocaine vs. home/cocaine, t = 1.91, P = 0.073; novel/amphetamine
vs. home/amphetamine, t = 1.53, P = 0.147). In contrast, there was a strong
effect of environment on the number of ENK+ cells that expressed c-fos
mRNA (novel/cocaine vs. home/cocaine, t = 3.01, P < 0.008; novel/
amphetamine vs. home/amphetamine, t = 3.31, P < 0.005). The novel/
cocaine and novel/amphetamine groups also had more c-fos/ENK+ cells
(t = 2.32±3.34, P < 0.033) and c-fos/DYN+ cells (t = 2.45±4.05, P < 0.026)
than the novel/saline group. Asterisks indicate that novel is greater than
home.
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containing the dorsal striatum were processed for dual in situ
hybridization using 35S-UTP and CTP-labelled riboprobes comple-
mentary to prodynorphin or proenkephalin (733-mer and 693-mer,
respectively; courtesy of Dr J. Douglass, Amgen, Thousand Oaks,
CA, USA) and a digoxigenin-UTP-labelled riboprobe complimentary
to c-fos (680-mer; courtesy of Dr T. Curran). The only alterations to
the published protocol were (i) 1.25 mg of linearized plasmid was
used to generate the digoxigenin-UTP-labelled probe, and (ii)
sections were incubated in 0.1 M glycine and 0.5% Triton-X 100,
pH 2.2, for 10 min at room temperature and later ®xed in 0.5%
glutaraldehyde. These latter steps were included because they help to
decrease the colour background after development of emulsion-
dipped slides (Day et al., 1999).
Single-labelled sections were exposed to X-ray ®lm (Kodak
Biomax, MR, USA) for approximately 3 days and then dipped in
emulsion (NTB2, Kodak) and stored at 4 °C. Dipped slides were
developed (D-19, Kodak), dehydrated in graded alcohols, cresyl-
violet stained, and coverslipped with Permount. Double-labelled
sections were dipped in Ilford KD-5 emulsion (Polysciences) and
stored at 4 °C (» 3 days for enkephalin and 2 weeks for dynorphin).
After development (D-19, Kodak), the slides were dehydrated in
graded alcohols and coverslipped with Permount.
Quanti®cation
Single-labelled sections were quanti®ed as described previously
(Badiani et al., 1998). Brie¯y, brain images were captured with a
CCD camera (TM-745, Pulnix, USA) from X-ray ®lm.
Semiquantitative analysis was performed on each brain image using
National Institute of Health image software. Pixels were counted
when the optical density values were greater than 3.5 SD above
background value (background obtained from corpus callosum;
macro written by Dr S. Campeau, University of Colorado, Boulder,
CO, USA). Data are represented as relative integrated optical density
in arbitrary units, which re¯ect both signal intensity and the number
of pixels above background, divided by total area (Badiani et al.,
1998; Day et al., 2001).
Double-labelled tissue from the dorsal striatum was quanti®ed
using a Leica microscope (Leitz DMR, Wetzler, Germany).
Digoxigenin-labelled cells appeared as a purple precipitate in
bright®eld conditions and 35S-labelled cells appeared as silver grains
in dark®eld conditions. A 250-mm2 eyepiece grid was used to
quantify the number of single- and double-labelled cells in three
locations in the dorsal striatum (see Fig. 1). These data were
combined because the pattern of expression did not differ across the
three locations.
Statistics
Group differences in c-fos mRNA expression were analysed using
planned t-tests. For all data, an initial comparison was made between
the untreated group and the home/saline group to determine the effect
of being picked up and given an i.p. injection of saline. For all
measures there were no differences between these groups, so they
were pooled to form one control group. For all comparisons a < 0.05.
Results
Expression of c-fos mRNA in the dorsal striatum
Figure 1 shows the results from analysis of the dorsal striatum. In the
control group the levels of expression were extremely low, and for all
graphs the data were normalized by subtracting the mean level of
expression in the control group. Therefore, values that are signi®-
cantly greater than zero represent an increase in c-fos mRNA
expression above control. The stippled areas on the illustrations to the
right of each graph indicate the portion of the dorsal striatum that was
analysed. We focused on this region of the dorsal striatum because it
is where we previously found the largest drug±environment inter-
action (Badiani et al., 1998).
Figure 1A shows the mean number of cells expressing c-fos
mRNA in the dorsal striatum for each group. The number of c-fos+
cells was increased signi®cantly above control in all groups (all
P < 0.05), but there were also signi®cant group differences. The
greatest number of c-fos mRNA+ cells was found in animals given
amphetamine or cocaine in a novel environment, and these groups
differed signi®cantly from all other groups (P < 0.02).
Figure 1B shows the mean number of c-fos mRNA+ cells in the
dorsal striatum that were also positive for either DYN mRNA or ENK
mRNA, for each group. Figure 2 provides illustrations of represen-
tative sections processed for dual in situ hybridization histochemistry.
When given at home or in a novel environment, both amphetamine
and cocaine induced c-fos mRNA expression in DYN+ cells, and
there was no signi®cant effect of environment. In contrast, there was
a large effect of environment on c-fos mRNA expression in ENK+
cells. When given at home, both amphetamine and cocaine increased
c-fos mRNA expression in very few ENK+ cells, and the home/
amphetamine group did not even differ from control. When given in a
novel environment, however, both amphetamine and cocaine
increased c-fos mRNA expression in many ENK+ cells, and in
signi®cantly more ENK+ cells than in the home/drug condition
(P < 0.008). Like psychostimulant drug treatment at home, saline
administered in a novel environment increased c-fos mRNA expres-
sion in very few ENK+ cells, although signi®cantly more than in the
control condition.
In summary, when given at home, amphetamine and cocaine
induced c-fos mRNA expression in many DYN+ cells, but only in
very few ENK+ cells. When given in a novel environment, however,
amphetamine and cocaine induced c-fos mRNA expression in
approximately equal numbers of DYN+ and ENK+ cells. Indeed,
the increase in the total number of cells positive for c-fos mRNA seen
when psychostimulants were given in a novel environment, relative to
when they were given at home (see Fig. 1A), was largely accounted
for by the increase in the number of ENK+ cells expressing c-fos
mRNA (compare Fig. 1A and B).
Subthalamic nucleus
Figure 3 shows the effect of environment on amphetamine- and
cocaine-induced c-fos mRNA levels in the STN. In the control group,
levels of c-fos mRNA were very low and the data were normalized by
subtraction of the average level of expression in control group (i.e.
control expression equals zero). The doses of amphetamine and
cocaine used here did not signi®cantly increase c-fos mRNA
expression in the STN when these drugs were administered at
home, nor did saline administration in a novel environment. In
contrast, when administered in a novel environment, both amphet-
amine and cocaine signi®cantly increased c-fos mRNA expression in
the STN (P < 0.01), and the levels of expression were signi®cantly
greater than in the home condition (P < 0.02). Figure 4 provides
representative densitograms.
Discussion
We report four major ®ndings. (i) In neurologically intact rats (our
previous studies were with rats that had a unilateral 6-OHDA lesion),
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both cocaine and amphetamine induced c-fos mRNA expression in
signi®cantly more cells in the dorsal striatum when the drugs were
administered in a novel environment than when they were admin-
istered in the home cage. (ii) When given at home, both amphetamine
and cocaine induced c-fos mRNA almost exclusively in striatal cells
that were positive for dynorphin mRNA (i.e. the ENK± cell
population). (iii) When given in a novel environment, however,
amphetamine and cocaine induced c-fos mRNA not only in DYN+
cells, but in approximately equal numbers of ENK+ cells. (iv)
Amphetamine and cocaine enhanced c-fos mRNA levels in the STN
when they were administered in a novel environment, but not when
they were administered at home.
Most researchers have reported that amphetamine and cocaine
increase c-fos mRNA or Fos-like immunoreactivity (Fos-IR) almost
exclusively in ENK± striatal neurons (Berretta et al., 1992; Cenci
et al., 1992a, b; Johansson et al., 1994; Ruskin & Marshall, 1994;
Kosofsky et al., 1995; Berke et al., 1998). For example, using
immunohistochemistry, Berretta et al. (1992, p.769) reported that in
rats given either amphetamine or cocaine `Fos-positive nuclei were
almost never found in enkephalin-positive neurons. Out of 2500 Fos-
positive nuclei plotted, only two ... were colocalized with
enkephalin'. Similarly, using in situ hybridization, Johansson et al.
(1994, p. 845) reported that `amphetamine and cocaine raised c-fos
mainly in substance P-positive cells, but rarely in enkephalin-positive
cells'. Therefore, our ®nding that amphetamine and cocaine increased
c-fos mRNA in many ENK+ cells appears, at ®rst glance, to be
inconsistent with the literature. However, to the best of our
knowledge, in all previous studies but one, psychostimulants were
given in the home cage. For example, in all the studies from the
Graybiel laboratory, amphetamine or cocaine was given in the home
cage (A. Graybiel, personal communication, 18 November 2000).
The one exception is a study by Jaber et al. (1995), who reported that
although amphetamine induced Fos-IR predominantly in ENK± cells
(77% of Fos+ cells were also substance P+), Fos was also expressed
in ENK+ cells (33% of Fos+ cells were ENK+). Indeed, these authors
report the highest level of psychostimulant-evoked IEG expression in
ENK+ cells in the literature, other than the present study and our
earlier study in rats with a unilateral 6-OHDA lesion (Badiani et al.,
1999). It is especially important to note, therefore, that Jaber et al.
(1995) treated rats in a test cage, not in their home cage.
It thus seems that the apparent selectivity of psychostimulant-
induced IEG expression in the striatum may be a function of where
drugs were administered. When given in a novel environment, the
effect of amphetamine and cocaine on c-fos was not restricted to one
population of projection neurons. This raises a number of questions
regarding the neurotransmitter systems thought to govern psychos-
timulant-induced IEG expression in the striatum. The ability of
amphetamine and cocaine to induce c-fos in the striatum is widely
thought to be DA-dependent. The ability of amphetamine or cocaine
to induce c-fos mRNA and Fos-IR in the striatum is decreased by a 6-
OHDA lesion (Cenci et al., 1992b; Bhat & Baraban, 1993; Cenci &
Bjorklund, 1994; Paul et al., 1995; Ishida et al., 1998), or by the
coadministration of D1 antagonists (Graybiel et al., 1990; Berretta
et al., 1992; Nguyen et al., 1992; Steiner & Gerfen, 1995; Yoshida
et al., 1995; Ishida et al., 1998), as is the expression of other IEGs,
including zif/268 and arc (Moratalla et al., 1992; Steiner & Gerfen,
1995; Daunais & McGinty, 1996; Kodama et al., 1998). The effect of
D2 antagonists is more mixed, and more dif®cult to interpret, because
D2 antagonists can themselves induce expression of c-fos (Graybiel
et al., 1990; Young et al., 1991; Ruskin & Marshall, 1994).
Nevertheless, LaHoste et al. (2000) reported recently that the D2
antagonist, L-741,626, but not the D3 antagonist, U99194A, or the
D4 antagonist, L-745,870, attenuated amphetamine-stimulated Fos-
IR in the striatum. However, all of these studies presumably
characterized c-fos expression primarily in ENK± cells, because
expression in ENK+ cells has not been studied.
Consistent with the notion that amphetamine-evoked c-fos mRNA
expression in ENK± cells is DA-dependent, we found that a 6-OHDA
lesion abolishes the ability of amphetamine to increase c-fos mRNA
in cells also positive for D1 receptor mRNA (ENK± cells), regardless
of environmental context. However, we also found that a 6-OHDA
lesion does not reduce c-fos mRNA in striatal neurons positive for D2
receptor mRNA (ENK+ cells) when amphetamine is administered in
a novel environment (Badiani et al., 1999). This is an important
®nding because it is the ®rst to suggest that different neurotransmitter
systems are responsible for psychostimulant-evoked increases in c-fos
mRNA expression in different striatal projection neurons, and that the
induction of c-fos in the ENK+ cell population requires the actions of
a neurotransmitter(s) other than DA.
At this point it is pure speculation as to what neurotransmitters are
involved in the induction of c-fos in ENK+ cells. Nevertheless, there
are reasons to suspect that glutamate may be involved. First, NMDA
receptor antagonists decrease amphetamine- and cocaine-evoked
expression of a number of IEGs in the striatum (Snyder-Keller, 1991;
Ohno et al., 1994; Wang et al., 1994; Wang & McGinty, 1996; Ishida
et al., 1998). Second, damage to corticostriatal afferents, which are
mostly glutamatergic, reduces IEG expression evoked by amphet-
amine (Cenci & Bjorklund, 1993; Cenci & Bjorklund, 1994). Third,
activation of corticostriatal ®bres by electrical stimulation induces c-
fos mRNA or Fos-IR in the striatum and STN (Fu & Beckstead, 1992;
FIG. 4. Representative densitograms illustrating the expression of c-fos mRNA (S35-labelled) in the subthalamic nucleus (STN) of rats administered cocaine
(COC) or amphetamine (AMPH). Increasing intensity of the signal is indicated by the transition from white to yellow to red. The cerebral peduncle (CP) is
labelled to assist with orientation.
FIG. 3. The expression of c-fos mRNA in the subthalamic nucleus of rats given cocaine or amphetamine (AMPH) at home, or in a novel environment, or
given saline in a novel environment, as indicated by analysis of optical density values (arbitrary units). The level of expression in the control group was very
low (mean 6 SEM, 2.8 6 1.33 units), and this value was subtracted from the value for each animal in all experimental groups. Thus, the mean of the control
group is represented by a value of zero, and all values greater than zero indicate signi®cant expression. Statistics: only animals administered amphetamine or
cocaine in a novel environment differed from the control group (one-sample t-tests: novel/saline, t = 1.48, P = 0.178; home/cocaine, t = 1.51, P = 0.17;
novel/cocaine, t = 3.6, P < 0.008; home/amphetamine, t = 1.67, P = 0.139; novel/amphetamine, t = 4.51, P < 0.002). Animals given cocaine or amphetamine
in a novel environment showed higher levels of c-fos mRNA expression than animals treated at home (novel/cocaine vs. home/cocaine, t = 3.07, P < 0.008;
novel/amphetamine vs. home/amphetamine, t = 2.57, P < 0.02). Both the novel/cocaine and novel/amphetamine groups differed from the novel/saline group
FIG. 2. Representative histological plates illustrating sections from the dorsal striatum double-labelled for c-fos mRNA and enkephalin (ENK) mRNA. Cells
positive for c-fos mRNA are visualized by the purple precipitate and cells positive for enkephalin mRNA by silver grains. White arrows indicate single-
labelled cells (c-fos+/ENK±). Black arrows indicate double-labelled cells (c-fos+/ENK+).
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Wan et al., 1992; Liste et al., 1995; Parthasarathy & Graybiel, 1997;
Sgambato et al., 1997), and this effect is attenuated by glutamate
antagonists (Liste et al., 1995; Berretta et al., 1997). Fourth, local
cortical disinhibition by application of the GABA-A antagonist,
picrotoxin (Arnauld et al., 1996; Berretta et al., 1997; Berretta et al.,
1999) or local infusion of glutamate agonists into the striatum,
induces Fos-IR in ENK+, but not ENK±, neurons (Berretta et al.,
1997). Fifth, when amphetamine or cocaine are given in a novel
environment there is a massive increase in c-fos mRNA expression
throughout the neocortex, including the prefrontal cortex and the
amygdala, which in part may re¯ect activation of glutamatergic
corticostriatal systems. This cortical activation is probably due the
action of a novel environment as a stressor (Cullinan et al., 1995),
because mere exposure to a novel environment (without drug)
increases corticosterone secretion and induces c-fos mRNA in the
neocortex and portions of the amygdala (Badiani et al., 1998; Uslaner
FIG. 2.
FIG. 3. FIG. 4.
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et al., 1999; Day et al., 2001). Importantly, these same cortical
systems are not engaged when amphetamine or cocaine are given at
home (Badiani et al., 1998; Uslaner et al., 1999; Day et al., 2001).
We hypothesize therefore that when amphetamine and cocaine are
given in a novel environment, the primary neuropharmacological
effects of these drugs on monoamine neurotransmission (which
predominate in the home condition) interact with the effects of
environmental novelty on corticostriatal glutamate systems, and this
interaction leads to the recruitment of the ENK+ cell population in the
striatum. The identity of the neurotransmitter systems that engage
corticostriatal cells is unknown, but neurotransmitter systems acti-
vated by stressors, such as monoamines, are prime suspects. Note,
however, that the cortical activation produced by exposure to a novel
environment alone (in the absence of drugs) is not suf®cient to engage
ENK+ cells or the STN (see Figs 1B and 3). This appears to require a
drug±environment interaction at the level of the striatum, and we
hypothesize this involves a monoamine±glutamate interaction.
Finally, it is tempting to speculate that engaging the ENK+ cell
population in the striatum leads to increased activity in the `indirect'
pathway, and that this accounts for the increase in c-fos mRNA
expression in the STN seen when amphetamine or cocaine are given
in a novel environment. It has been reported previously that
amphetamine increases Fos-IR (Wirtshafter & Asin, 1999), glucose
utilization (Trugman & James, 1993; Pontieri et al., 1995) and unit
activity (Olds et al., 1999) in the STN, although in these studies the
effect of environmental context was not examined. Of course, it is
also possible that the effect of environmental novelty on psychos-
timulant-evoked c-fos mRNA expression in the STN is not related
directly to the recruitment of ENK+ cells in the striatum, but to
activation of one of many other afferents to the STN, including those
arising in the neocortex (for review seeParent & Hazrati, 1995).
It is worth noting that the monoamine±glutamate interaction
hypothesized here may not only facilitate striatal and STN IEG
expression, but because psychostimulant administration in a novel
environment facilitates behavioural sensitization (Badiani et al.,
1995a, b; Crombag et al., 1996; Browman et al., 1998), it may also
promote drug experience-dependent neuroplasticity. Indeed, stimula-
tion of the STN can produce long-term potentiation (LTP)-like
changes in the substantia nigra (Overton et al., 1999). This is
important because of the proposed relationship between LTP,
sensitization and glutamate neurotransmission (Wolf, 1998).
Conclusions
In conclusion, the pattern of gene expression induced by psychos-
timulant drugs is determined, to an amazing extent, by the setting in
which these drugs are experienced. This may account for some of the
effects of environmental novelty on both the acute psychomotor
actions of these agents, as well as their ability to induce drug
experience-dependent neuroplasticity. Most importantly, these data
indicate that to understand the neurobiological actions of drugs of
abuse that are critical in the development of addiction, such as their
ability to promote neuroplasticity, we must pay close attention not
only to their direct pharmacological actions, but also, as put by Falk
& Feingold (1987, p. 1503), to the `cluster of interactions among the
pharmacological substance, the individual set of the organism, and
the environmental setting'.
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